A socially oriented non-financial development institution and a major organizer of international conventions, congress, exhibitions, business, social and sporting, public, and cultural events.

The Roscongress Foundation – a socially oriented non-financial development institution and a major organizer of international conventions, congress, exhibitions, business, social and sporting, public, and cultural events.

The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, and helps foster social entrepreneurship and charitable initiatives.

Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 5000 people working in Russia and abroad. In addition, it works in close cooperation with 129 economic partners; industrialists’ and entrepreneurs’ unions; and financial, trade, and business associations from 69 countries worldwide.

RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Finding the right balance in domestic and foreign drug production
18 June 2016
08:30

In recent years, Russia has charted a clear course for domestic pharmaceutical production, targeting an almost doubling of in-country production with the aim of reaching 50% by 2020. At the same time, there are plans to bring the legal framework for the drug market in line with international standards. How is this policy being implemented, and how might it impact both foreign and domestic producers over the coming years? What main problems are being encountered by the sector and what should be done to overcome these issues? What steps need to be taken to ensure that Russian patients have uninterrupted access to quality medicines?

Date
18.06.2016
Forum
SPIEF
Started at
08:30
Analytics on the topic